Valaris stock slips as analysts keep a Reduce view

Published on 09/17/2026 at 17:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Valaris stock was quoted at USD 83.01 on September 16, 2026, after a 0.59 percent move. MarketBeat put the consensus target at USD 66.60 and the average rating at Reduce.

VAL, BMG9319H1053, Illustration mit AI erstellt.

Valaris stock (BMG9319H1053) was quoted at USD 83.01 on September 16, 2026, after rising 0.59 percent to close at 4:00:02 PM EDT. The main read-through comes from MarketBeat, which said on September 16, 2026 that the consensus rating was Reduce and the average price target was USD 66.60.

Analysts still lean cautious

MarketBeat also reported that six analysts rate the shares Hold and one rates them Sell, leaving Valaris with an average rating of Reduce on September 16, 2026. That split matters because the consensus target of USD 66.60 sits below the recent quote of USD 83.01, a gap of USD 16.41.

In the same report, MarketBeat said Susquehanna lifted its target from USD 75.00 to USD 80.00 and kept a neutral rating. The new target still trails the market price, so the stock is priced above that house view even after the raise.

Revenue and earnings base

MarketBeat said Valaris reported revenue of USD 539.20 million for the quarter, down 12.4 percent year over year, while earnings per share came in at USD 0.72 versus USD 1.61 a year earlier. It also cited a return on equity of 9.25 percent and a net margin of 43.95 percent for the quarter.

The same snippet said analysts expect USD 3.25 in earnings per share for the current fiscal year. For investors, that makes the next reported period more important than the one just cited, because the current valuation already sits above the consensus target and above Susquehanna's USD 80.00 view.

Price stays above target

The shares changed hands at USD 83.01 on September 16, 2026, in New York, with the quote up 0.59 percent on the session. The price is still above the USD 66.60 consensus target and the USD 80.00 Susquehanna target, which keeps the analyst debate anchored on execution rather than a re-rating.